Bluejay Investor Presentation Deck

Management & Advisors: Leadership, Diagnostic & Product Launch Expertise ●●● Indranil "Neil" Dey CEO and Co-founder ● Involved in introducing Her2neu test for Herceptin Lead numerous global teams • Ph.D. in Biochemistry (UNESCO fellow) from BRC, Hungary, MBA (Fulbright Scholar) from Cambridge University, UK IMPATH The Cancer Information Company bluejay DIAGNOSTICS Frances Scally Interim-CFO ● Responsible for Bluejay's finance, investor relations, accounting, and administrative operations. • CPA: B.S. in Accounting, Long Island University MA Jason Cook Chief Technology Officer ● ● Responsible for Bluejay's research and development, clinical affairs, and regulatory affairs 15+ years in medical device development Ph.D. in Biomedical Engineering, University of Texas at Austin TEXAS The University of Texas at Austin Les DeLuca VP Operations ● Responsible for Bluejay's technology transfer, manufacturing operations, and supply chain logistics • 30+ years in IVDs, including bringing numerous instrumental products to market ● BS, Chemistry, Worcester State College SEKISUI DIAGNOSTICS Mark Feinberg Chief Medical Advisor ● ● Guide Bluejay's clinical development programs Strategic medical leadership • Associate Professor, Harvard Medical School/Cardiovascular, Brigham & Women's; Medical College of Pennsylvania (LEI) Brigham and Women's Hospital Founding Member, Mass General Brigham Copyright ©2023 Bluejay Diagnostics, Inc. All rights reserved in all slides | November 2023 16

View entire presentation